Physician profile
Albert C Lee
NPI 1790815322
$1,540.46
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $443 · 2020: $204 · 2021: $464 · 2022: $281 · 2023: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $148.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $200.22 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $198.75 | 2019-2023 | |
| Ucb, INC. | $187.73 | 2019-2022 | |
| Sk Life Science, INC. | $106.71 | 2020-2023 | |
| Janssen Pharmaceuticals, INC | $87.93 | 2020-2023 | Ponvory |
| Eisai INC. | $84.99 | 2021-2022 | |
| Genzyme Corporation | $71.03 | 2019-2022 | |
| Emd Serono, INC. | $65.03 | 2019-2022 | |
| Greenwich Biosciences, INC. | $64.41 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $48.13 | 2020-2021 | |
| Ge Healthcare | $41.10 | 2019 | |
| Horizon Therapeutics Plc | $39.55 | 2022-2023 | Uplizna |
| Alexion Pharmaceuticals, INC. | $39.48 | 2019-2021 | |
| Biogen, INC. | $39.07 | 2019 | |
| Neurelis, INC. | $38.65 | 2020-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $38.01 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $34.95 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $28.09 | 2022 | |
| Allergan, INC. | $26.56 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $22.50 | 2021 | |
| Avanir Pharmaceuticals, INC. | $18.62 | 2019 | |
| Livanova USA, INC. | $16.69 | 2023 | Vns Therapy Sentiva Model 1000 Generator |
| Mallinckrodt Hospital Products INC. | $15.27 | 2023 | Acthar |
| Amneal Pharmaceuticals LLC | $14.32 | 2021 | |
| Banner Life Sciences, LLC | $12.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.